{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:52:30Z","timestamp":1791186750009,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20ck0106605"],"award-info":[{"award-number":["JP20ck0106605"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ck0106852"],"award-info":[{"award-number":["JP23ck0106852"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP26ck0106143"],"award-info":[{"award-number":["JP26ck0106143"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"DOI":"10.1007\/s12185-026-04294-z","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:09:57Z","timestamp":1791184197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-hoc analysis of induction failure in pediatric LCH: the JLSG-02 and LCH-12 clinical trials"],"prefix":"10.1007","author":[{"given":"Yukayo","family":"Terashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-538X","authenticated-orcid":false,"given":"Kenichi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Shioda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Osone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Imashuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"4294_CR1","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1182\/blood.2019000934","volume":"135","author":"C Rodriguez-Galindo","year":"2020","unstructured":"Rodriguez-Galindo C, Allen CE. Langerhans cell histiocytosis. Blood. 2020;135:1319\u201331.","journal-title":"Blood"},{"key":"4294_CR2","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1182\/blood-2012-09-455774","volume":"121","author":"H Gadner","year":"2013","unstructured":"Gadner H, Minkov M, Grois N, P\u00f6tschger U, Thiem E, Aric\u00f2 M, et al. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013;121:5006\u201314.","journal-title":"Blood"},{"key":"4294_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12185-016-1993-3","volume":"104","author":"A Morimoto","year":"2016","unstructured":"Morimoto A, Shioda Y, Imamura T, Kudo K, Kawaguchi H, Sakashita K, et al. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans cell histiocytosis study group-02 protocol study. Int J Hematol. 2016;104:99\u2013109.","journal-title":"Int J Hematol"},{"key":"4294_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12185-023-03568-0","volume":"118","author":"A Morimoto","year":"2023","unstructured":"Morimoto A, Shioda Y, Kudo K, Kanegane H, Imamura T, Koh K, et al. Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study. Int J Hematol. 2023;118:107\u201318.","journal-title":"Int J Hematol"},{"key":"4294_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"4294_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/ped.13792","volume":"61","author":"Y Oh","year":"2019","unstructured":"Oh Y, Hayase T, Ito T, Kawahara Y, Morimoto A. Cladribine-related myelodysplastic syndrome in Langerhans cell histiocytosis. Pediatr Int. 2019;61:419\u201321.","journal-title":"Pediatr Int"},{"key":"4294_CR7","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1182\/blood-2015-03-635151","volume":"126","author":"J Donadieu","year":"2015","unstructured":"Donadieu J, Bernard F, van Noesel M, Barkaoui M, Bardet O, Mura R, et al. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study. Blood. 2015;126:1415\u201323.","journal-title":"Blood"},{"key":"4294_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/bjh.16449","volume":"189","author":"MA Barkaoui","year":"2020","unstructured":"Barkaoui MA, Queheille E, Aladjidi N, Plat G, Jeziorski E, Moshous D, et al. Efficacy of cladribine for refractory or severe multisystem Langerhans cell histiocytosis: analysis of 23 cases from the French histiocytosis group and systematic literature review. Br J Haematol. 2020;189:869\u201378.","journal-title":"Br J Haematol"},{"key":"4294_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/pbc.22229","volume":"53","author":"S Weitzman","year":"2009","unstructured":"Weitzman S, Braier J, Donadieu J, Egeler RM, Grois N, Ladisch S, et al. 2\u2019-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH): results of the LCH-S-98 protocol of the histiocyte society. Pediatr Blood Cancer. 2009;53:1271\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"4294_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/pbc.24772","volume":"61","author":"SJ Simko","year":"2014","unstructured":"Simko SJ, Tran HD, Jones J, Bilgi M, Beaupin LK, Coulter D, et al. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease. Pediatr Blood Cancer. 2014;61:479\u201387.","journal-title":"Pediatr Blood Cancer"},{"key":"4294_CR11","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1111\/bjh.19376","volume":"204","author":"D Parekh","year":"2024","unstructured":"Parekh D, Lin H, Batajoo A, Peckham-Gregory E, Karri V, Stanton W, et al. Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis. Br J Haematol. 2024;204:1888\u201393.","journal-title":"Br J Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04294-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04294-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04294-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:09:58Z","timestamp":1791184198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04294-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":11,"alternative-id":["4294"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04294-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"13 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}